<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>151</id><JournalTitle>MOLECULAR DOCKING AND ADMET ANALYSIS OF PHYLLANTHUS EMBLICA PLANT CONSTITUENTS WITH MULTIPLE PHARMACOLOGICAL ACTIVITIES</JournalTitle><Abstract>Phyllanthus emblica, commonly known as Amla or Indian gooseberry, is an important medicinal plant widely recognized for
its diverse pharmacological properties. It belongs to the family Phyllanthaceae and has traditionally been used in various
systems of medicine for the management of several health disorders. The present study was carried out to investigate the
molecular docking potential of selected phytoconstituents of P. emblica against multiple therapeutic targets. Important
phytoconstituents, including Gallic acid, Ellagic acid, Ascorbic acid, Quercetin, Catechol, D-glucose, Inositol, and other
selected bioactive compounds, were evaluated for their binding affinity and molecular interactions with target proteins
associated with different pharmacological activities. The target proteins were obtained from the RCSB Protein Data Bank and
prepared using appropriate molecular modelling software. Molecular docking was performed using Auto Dock, and the
interactions were evaluated based on binding energy, inhibition constant, and amino acid residue interactions. Lower negative
binding energy and favourable molecular interactions were considered indicators of stronger predicted binding affinity. The
selected phytoconstituents demonstrated varying degrees of interaction with different therapeutic targets, suggesting their
potential contribution to the antioxidant, anti-inflammatory, antidiabetic, cardioprotective, hepatoprotective, and other
pharmacological activities of P. emblica. Overall, the findings suggest that the bioactive constituents of Phyllanthus emblica
may interact favourably with multiple molecular targets and could serve as potential lead molecules for further drug discovery
research. However, molecular docking provides only computational predictions; therefore, further in-vitro, in-vivo, and
experimental studies are required to validate their pharmacological activity and safety</Abstract><Email>kloganathanbholu@gmail.com</Email><articletype>Research</articletype><volume>16</volume><issue>2</issue><year>2026</year><keyword>Phyllanthus emblica, Amla, Phytoconstituents, Molecular Docking, Gallic acid, Ellagic acid, Antioxidant, Antiinflammatory, Antidiabetic, Computational Drug Discovery</keyword><AUTHORS>Dr. Saravanan C,Loganathan K</AUTHORS><afflication>1Professor Cum HOD Department of Pharmaceutical Analysis, Aadhibhagawan College of Pharmacy, Rantham Village, Thiruvannamalai District-604407, Tamil Nadu, India,B. Pharm Final Year, Aadhibhagawan College of Pharmacy, Rantham Village, Thiruvannamalai District-604407, Tamil Nadu, India</afflication></Article></Articles>